Bioqual Price to Book Ratio 2012-2025 | BIOQ
Historical price to book ratio values for Bioqual (BIOQ) over the last 10 years. The current price to book ratio for Bioqual as of May 15, 2026 is 0.94.
| Bioqual Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-05-15 | 35.20 | 0.00 | |
| 2025-11-30 | 38.51 | 0.00 | |
| 2025-08-31 | 43.19 | $40.14 | 1.08 |
| 2025-05-31 | 45.00 | $40.42 | 1.11 |
| 2025-02-28 | 60.00 | $40.53 | 1.48 |
| 2024-11-30 | 67.50 | $39.48 | 1.71 |
| 2024-08-31 | 69.47 | $41.34 | 1.68 |
| 2024-05-31 | 71.95 | $42.09 | 1.71 |
| 2024-02-29 | 70.00 | $43.41 | 1.61 |
| 2023-11-30 | 63.52 | $43.10 | 1.47 |
| 2023-08-31 | 63.96 | $43.06 | 1.49 |
| 2023-02-28 | 102.34 | $42.84 | 2.39 |
| 2022-11-30 | 69.87 | $44.11 | 1.58 |
| 2022-08-31 | 72.82 | $43.67 | 1.67 |
| 2022-05-31 | 67.96 | $42.12 | 1.61 |
| 2022-02-28 | 87.38 | $40.01 | 2.18 |
| 2021-11-30 | 97.83 | $39.05 | 2.51 |
| 2021-08-31 | 68.85 | $39.03 | 1.76 |
| 2021-05-31 | 77.55 | $37.49 | 2.07 |
| 2021-02-28 | 81.56 | $35.11 | 2.32 |
| 2020-11-30 | 72.20 | $34.02 | 2.12 |
| 2020-08-31 | 61.38 | $33.49 | 1.83 |
| 2020-05-31 | 56.44 | $31.51 | 1.79 |
| 2020-02-29 | 51.74 | $30.06 | 1.72 |
| 2019-11-30 | 45.62 | $29.25 | 1.56 |
| 2019-08-31 | 28.56 | 0.00 | |
| 2019-05-31 | 33.17 | $27.46 | 1.21 |
| 2019-02-28 | 35.93 | 0.00 | |
| 2018-11-30 | 34.09 | 0.00 | |
| 2018-08-31 | 28.51 | 0.00 | |
| 2018-05-31 | 30.27 | $24.65 | 1.23 |
| 2018-02-28 | 32.58 | 0.00 | |
| 2017-11-30 | 35.30 | 0.00 | |
| 2017-08-31 | 31.67 | 0.00 | |
| 2017-05-31 | 32.56 | 0.00 | |
| 2017-02-28 | 32.34 | 0.00 | |
| 2016-11-30 | 28.55 | 0.00 | |
| 2016-08-31 | 21.09 | 0.00 | |
| 2016-05-31 | 19.99 | 0.00 | |
| 2016-02-29 | 15.80 | 0.00 | |
| 2015-11-30 | 12.49 | 0.00 | |
| 2015-08-31 | 12.92 | 0.00 | |
| 2015-05-31 | 14.47 | 0.00 | |
| 2015-02-28 | 13.35 | 0.00 | |
| 2014-08-31 | 6.96 | 0.00 | |
| 2014-05-31 | 6.75 | 0.00 | |
| 2013-08-31 | 4.94 | 0.00 | |
| 2013-05-31 | 5.28 | 0.00 | |
| 2012-05-31 | 7.87 | 0.00 | |
| 2012-02-29 | 7.25 | 0.00 | |
| 2011-11-30 | 5.76 | 0.00 | |
| 2011-08-31 | 5.00 | 0.00 | |
| 2011-02-28 | 6.65 | 0.00 | |
| 2010-11-30 | 6.65 | 0.00 | |
| 2009-11-30 | 9.87 | 0.00 | |
| 2009-08-31 | 9.36 | 0.00 | |
| 2009-05-31 | 9.36 | 0.00 | |
| 2008-05-31 | 11.17 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.034B | $0.049B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |